Sanofi has received FDA breakthrough therapy designation for Wayrilz to treat warm autoimmune hemolytic anemia, a rare disorder with no approved targeted therapies. Japan has also granted orphan status.
Natco Pharma has received High Court approval to manufacture and export semaglutide, strengthening its entry into the global diabetes and obesity drug market and expanding its presence in metabolic disorder treatments.
The merger of Auro Vaccines and Curateq Biologics, a part of Aurobindo Pharma, was approved today during a board meeting of the company held.
.jpeg "MedGenome Launches MetaSeq to Identify 1,400+ Pathogens in One Test")
MedGenome launches MetaSeq, an advanced blood test using NGS to detect 1,400+ pathogens in just five days, offering faster, more accurate diagnosis for bloodstream infections.
.png "AstraZeneca Pharma India Gets CDSCO Approval for Imfinzi")
AstraZeneca Pharma India has received CDSCO approval to import and market Imfinzi for an additional cancer indication, expanding treatment options for advanced and recurrent endometrial cancer patients in India.
.png "Eli Lilly Acquires Orna to Advance In Vivo CAR-T Therapies")
Eli Lilly has agreed to acquire Orna Therapeutics in a deal valued at up to $2.4 billion, strengthening its position in in vivo CAR-T therapies and expanding options for patients with B cell-driven autoimmune diseases.
Takeda Pharmaceutical has signed a major $1.7 billion deal with biotech firm Iambic, marking a fresh push to use AI drug discovery to speed up small-molecule research in cancer and gastrointestinal diseases.
Piramal Pharma has partnered with Blue-Zone Technologies to recycle waste anaesthetic gases through its subsidiary Piramal Critical Care, aiming to cut environmental impact while ensuring continued access to essential anaesthesia products.
.png "Pfizer's Hympavzi Receives FDA Priority Review for Haemophilia")
Pfizer’s Hympavzi (marstacimab) has received FDA Priority Review for treating haemophilia A or B patients aged 6 and older with inhibitors, as well as paediatric patients (ages 6-11) without inhibitors.
Alembic Pharmaceuticals has secured USFDA approval for its generic Carbidopa, Levodopa, and Entacapone tablets.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")